申请人:BETAGERI Rajashekhar
公开号:US20120322790A1
公开(公告)日:2012-12-20
Disclosed are compounds of the formula (I), useful for treating a variety of diseases and disorders that are mediated or sustained through the activity of CCR1 including autoimmune diseases, such as rheumatoid arthritis and multiple sclerosis.
Also disclosed are methods of making and methods of using same.